online digital cash company Top People searches

The Nikkei 225 index closed at 39,881.10 points in early trading, up 1.29%.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.The National Green Development Fund and other companies have established ecological restoration production and investment partnerships. According to the enterprise survey APP, recently, Jiangxi Green Gold Ecological Restoration Industry Investment Partnership (Limited Partnership) was established with a capital contribution of 1 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the company is jointly owned by National Green Development Fund Co., Ltd. and Jiangxi Jinkong Investment Group Co., Ltd.

The annual passenger flow at the West Kowloon Station Port exceeded 25 million for the first time. It was learned from the West Kowloon Border Inspection Station of Shenzhen Border Inspection Station that as of 24: 00 on December 11th, the cumulative passenger flow at the West Kowloon Border Inspection Station exceeded 25 million for the first time this year, accounting for 36.7% of the total passenger flow since the opening of the West Kowloon Station Port, an increase of 36.5% compared with last year, an increase of 33% on average daily passenger flow, and 32.5% of foreign passengers entering the country without visas. Inspection ensures that cross-border trains increase by 36% year-on-year, and "customs clearance flow" helps "economic growth", injecting border inspection momentum into the country's high-level open and high-quality development. (Voice of Greater Bay Area)Shibor reported 1.4820% overnight, down 4.6 basis points; In 7 days, shibor reported 1.6350%, down 8.7 basis points; In three months, shibor reported 1.7400%, down 0.4 basis points.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.

The concept of robots has partially returned, and the Wuzhou New Year, Yuanda Intelligent daily limit, Great Wheel Intelligence, Mingke Jingji, Astar, Fengli Intelligent, Sanfeng Intelligent, etc. have followed suit.The bauxite of the Guinea project of Tianshan Aluminum Group was shipped for the first time. According to the news of Tianshan Aluminum Group, on the afternoon of December 11th, local time in Guinea, Zeng Chaolin, the chairman of the company, attended and presided over the first shipment ceremony of the bauxite of Guinea project. This inaugural ceremony marks that the whole chain of the project has entered the operation stage. Subsequently, the company will increase infrastructure investment and mining scale, and gradually increase production capacity and transportation capacity. It is expected that the bauxite self-sufficiency rate will be 100% within two years, ensuring the company to obtain stable and low-cost bauxite resources and continuously maintain the competitive advantage of the integrated industrial chain.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.